Dideoxycytidine → Diisopropylaminomethylene 2',3'-dideoxycytidine

HRID 1419455

Reaktionsgleichung

Reaktionsgleichung von HRID 1419455
[C@@H:1]1([N:8]2[CH:15]=[CH:14][C:12]([NH2:13])=[N:11][C:9]2=[O:10])[O:7][C@H:4]([CH2:5][OH:6])[CH2:3][CH2:2]1.CO[CH:18](OC)[N:19]([CH:23]([CH3:25])[CH3:24])[CH:20]([CH3:22])[CH3:21]>CN(C=O)C>[CH:20]([N:19]([CH:18]=[C:2]1[CH2:3][C@@H:4]([CH2:5][OH:6])[O:7][C@H:1]1[N:8]1[CH:15]=[CH:14][C:12]([NH2:13])=[N:11][C:9]1=[O:10])[CH:23]([CH3:25])[CH3:24])([CH3:22])[CH3:21]

Komponenten

4

Edukt 2

HCID 24066DideoxycytidineHCID 13161384Diisopropylformamide Dimethylacetal (>90%)

Produkt 1

HCID 131717010Diisopropylaminomethylene 2',3'-dideoxycytidineAusbeute 79,3 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

In a typical example of such procedure, previously dried 2', 3'-dideoxycytidine (153 mg, 0.724 mmoles) which was previously prepared by the literature procedures described above is treated with diisopropylformamide dimethylacetal (1.27 g, 7.24 mmoles) in anhydrous DMF (2 mL) under an argon atmosphere. The product is stirred overnight and thereafter solvent and excess reagent are removed by rotary evaporation. The syrupy residue remaining is crystallized from ethanolether to give pale lemon-colored crystals (185 mg, 79%) of diisopropylaminomethylene 2', 3'-dideoxycytidine.

Aufarbeitung

  1. customsolvent and excess reagent are removed by rotary evaporation
  2. customThe syrupy residue remaining is crystallized from ethanolether

Quellen und Nachweise

ORD-Eintrag
ord-6996bb5d200c4eb2b91a51600ce8e971
Quelldatensatz
uspto-grants-1999_03
Patentnummer
US05886162

Verknüpfte Notizen

Wird geladen…